ST STZ Constellation Brands Loading... : Bullish and Bearish Analyst Opinions

US beer weak, global beer strong

Constellation Brands a steal after sell-off.

Beer earnings bottom, bargain steal

BofA trimmed STZ; consumer spending rotation from goods to experiences (travel over staples) cited as headwind.

Morgan Stanley cuts Constellation Brands PT to $158; speaker lists the action with no specific bearish thesis or mechanism provided.

Seeking Alpha reports Constellation Brands' mixed earnings with beer growth offsetting wine/spirits decline, but the Quant system rates it a HOLD, not a trade recommendation.

Pre-market movers report shows Shutterstock plunging 32% on merger termination, Caterpillar falling 2.5% after Michael Burry disclosed a short position, and Microsoft rising 2% on plans for fresh job cuts.

Shares a news article about beer demand ahead of the World Cup, no personal directional commitment.

Alcohol stocks are bottoming, buy now.

The tweet notes that several alcoholic beverage companies like STZ, BFb, and BUD have non-voting share structures, but offers no forward-looking market view or trade thesis.

Constellation Brands is a buy as alcohol bottoms.

Cramer said he is "excited about the possibilities" for Constellation Brands, believes its new CEO can revitalize the business, and sees a "subtle turn in beer and a definite turn in the ready to drink cocktail market." He concluded, "STZ, I think it might be worth even buying ahead." The company owns the top beer in the country (Modelo). He believes the headwinds in liquor are known, but an improving trend in its core beer and RTD segments under new leadership makes the stock attractive. The stock is a buy based on a potential turnaround and positive secular shifts in its key markets. The turn in consumer trends does not materialize, or GLP-1 drug impact on alcohol consumption is more severe than anticipated.

Rogers states, "Americans no longer are drinking alcohol the way they used to." A secular decline in alcohol consumption (health trends, GLP-1 drugs) makes the "moat" of beer and spirits companies structurally weaker. They are value traps. AVOID Alcohol/Spirits stocks. International growth offsets US decline.

"I'm looking at, for instance, LVMH, Moet Hennessy in Europe, climbing on the news, up 4.4%... companies that rely on exports to the U.S. also benefiting." The ruling specifically removes threats on "French wine" and other foreign goods. European luxury and beverage companies regain price competitiveness in the US market without the artificial tax wedge. LONG European Exporters, specifically Luxury and Spirits. Retaliatory measures from the US administration using different legal frameworks (e.g., National Security grounds).

Spevak observes a major demographic shift: "Everybody knows drinking is way down." Young people want to be in bed by 11 PM to hit the gym the next morning rather than partying late. The "high-performance lifestyle" is fundamentally incompatible with heavy alcohol consumption. As health/longevity becomes the ultimate status symbol, alcohol volume (especially among high-net-worth individuals and youth) faces a secular headwind. Avoid major alcohol producers as social habits shift toward wellness and recovery. Alcohol companies successfully pivoting to non-alcoholic beverages (which they are attempting).